18:45 - 20:15
Maimonides Hall

SugarBEAT® Non-Invasive CGM User Study Results: Diagnostic and Monitoring Applications Across Different Patient Types and Clinical Settings

Evening Session

Welcome and Introduction
Development History - Initial Idea to Key Milestones in SugarBeat®'s Development
SugarBeat® Technology - Overview and how it differs from invasive CGM technologies (electrochemical and fluorescence), MARD, calibration, Glucose Trending®
Clinical Use: T2 Oral / Insulin Treated Patients / Diagnosing Pre-Diabetics / Therapy Optimisation & Intensification / Weight & Nutrition Management
Patient User-Experience: T2 Oral / T2 Insulin
Questions & Answers
Symposium by: